These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18337287)

  • 61. Statement of guiding principles for the provision of clinical pharmacy services approved by the Canadian Society of Hospital Pharmacists May 1975.
    Can J Hosp Pharm; 1975; 28(5):144. PubMed ID: 10236912
    [No Abstract]   [Full Text] [Related]  

  • 62. ASHP national survey of pharmaceutical services in federal hospitals--1993.
    Crawford SY; Santell JP
    Am J Hosp Pharm; 1994 Oct; 51(19):2377-93. PubMed ID: 7847403
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dose-dispensing service as an intervention to improve adherence to polymedication.
    Hersberger KE; Boeni F; Arnet I
    Expert Rev Clin Pharmacol; 2013 Jul; 6(4):413-21. PubMed ID: 23927669
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Functional and structural prerequisites for clinical pharmacy services.
    Phillips JO; Strand LM; Chesteen SA; Morley PC
    Am J Hosp Pharm; 1987 Jul; 44(7):1598-605. PubMed ID: 3631090
    [TBL] [Abstract][Full Text] [Related]  

  • 65. ASHP national survey of hospital pharmaceutical services--1987.
    Stolar MH
    Am J Hosp Pharm; 1988 Apr; 45(4):801-18. PubMed ID: 3376964
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evaluation of facsimile cards for pharmacy-access products containing pseudoephedrine or ephedrine.
    Chanda S; Sansgiry SS
    J Am Pharm Assoc (2003); 2008; 48(1):52-7. PubMed ID: 18192131
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Improved medicine lists with multi-dose packaging?].
    Bakken T; Straand J
    Tidsskr Nor Laegeforen; 2003 Dec; 123(24):3595-7. PubMed ID: 14691514
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacist counsling increases drug regimen compliance.
    Dickey FF; Mattar ME; Chudzik GM
    Hospitals; 1975 May; 49(9):85-6, 88. PubMed ID: 47833
    [No Abstract]   [Full Text] [Related]  

  • 69. Hospital pharmacy services in the Great Lakes region.
    Raehl CL; Bond CA; Pitterle ME
    Am J Hosp Pharm; 1990 Jun; 47(6):1283-303. PubMed ID: 2368722
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Legal format and costs of prescriptions at the Central Hospital in Yaounde, Cameroon].
    Blatt A; Chambon R; Lemardeley P
    Med Trop (Mars); 1997; 57(1):37-40. PubMed ID: 9289607
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacists' opinions about and compliance with recommendations for intravenous admixture practices.
    Brzozowski DF; Hale KM; Segal R; Mirtallo JM
    Am J Hosp Pharm; 1987 Sep; 44(9):2077-84. PubMed ID: 3479020
    [TBL] [Abstract][Full Text] [Related]  

  • 72. ASHP technical assistance bulletin on compounding nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1994 Jun; 51(11):1441-8. PubMed ID: 7942879
    [No Abstract]   [Full Text] [Related]  

  • 73. [Evolution of the legal and normative framework surrounding the practice of hospital pharmacy and the correct use of drugs in Quebec].
    Chabrier A; Lebel D; Bussières JF
    Ann Pharm Fr; 2019 Nov; 77(6):496-505. PubMed ID: 31564420
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Unit dose radiopharmaceutical service as a component of total pharmacy practice.
    Barker LF; Evans WE
    Am J Hosp Pharm; 1976 Jan; 33(1):61-3. PubMed ID: 1266868
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Assessing unit dose system discrepancies.
    Max BE; Itokazu G; Danziger LH; Weinstein RA
    Am J Health Syst Pharm; 2002 May; 59(9):856-8. PubMed ID: 12004466
    [No Abstract]   [Full Text] [Related]  

  • 76. [Development of an inspection-supporting system using drug images for unit dose packages].
    Takayama K; Seino T; Sugiura M; Yamamura Y; Nakamura H; Sato H; Yamada Y; Iga T
    Yakugaku Zasshi; 2001 Nov; 121(11):821-8. PubMed ID: 11725551
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Using human factors methods to evaluate the labelling of injectable drugs.
    Momtahan K; Burns CM; Jeon J; Hyland S; Gabriele S
    Healthc Q; 2008; 11(3 Spec No.):122-8. PubMed ID: 18382173
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lack of commercial oral drug formulations for children in two hospital group purchasing agreements in france and Canada.
    Prot-Labarthe S; Bussieres JF; Barret P; Bourdon O; Brion F
    Int J Pharm Compd; 2008; 12(4):365-7. PubMed ID: 23969773
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Conformity with Optimal Drug-Use Processes: Comparison between the Accreditation Canada Managing Medications Standards and the Hospital Pharmacy in Canada Report.
    Barthélémy I; Lebel D; Vaillancourt R; Niro C; Mitchell J; Bussières JF
    Can J Hosp Pharm; 2014 Mar; 67(2):108-15. PubMed ID: 24799720
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Survey of state requirements for unit-of-use packaging.
    Szeinbach SL; Baron M; Guschke T; Torkilson EA
    Am J Health Syst Pharm; 2003 Sep; 60(18):1863-6. PubMed ID: 14521038
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.